Advertisement

Organisation › Details
Sanofi (Group) [since May 2011]
Sanofi-aventis is the world's third largest pharmaceutical company, ranking number one in Europe. Backed by a world-class R&D organization, Sanofi-aventis is developing leading positions in seven major therapeutic areas: cardiovascular, thrombosis, oncology, metabolic diseases, central nervous system, internal medicine, and vaccines. Sanofi-aventis is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY). *
![]() |
Start | 2011-05-06 renamed |
Predecessor | Sanofi-Aventis (Group) | |
![]() |
Industry | pharmaceutical |
![]() |
Person | Hudson, Paul (Sanofi 201909– CEO before Novartis Head Pharma before AstraZeneca + Schering-Plough) |
Person 2 | Contamine, Jérôme (Sanofi 2009–201809 CFO RETIRED 9/18) | |
![]() |
Region | Paris |
Country | France | |
Street | 174 avenue de France | |
City | 75635 Paris | |
Tel | +33-1-5377-4000 | |
Address record changed: 2020-12-02 | ||
Basic data | Employees | I: 50,001 to 100,0 (2021-12-31) |
Currency | EUR | |
Annual sales | 37,761,000,000 (sales, net, consolidated (2021) 2021-12-31) | |
Profit | 6,279,000,000 (2021-12-31) | |
Cash | 10,098,000,000 (2021-12-31) | |
* Document for »About Section«: | ||
Record changed: 2024-02-12 |
Advertisement

More documents for Sanofi (Group) [since May 2011]
- [1] Sanofi S.A.. (12/19/24). "Press Release: Jean-Paul Kress to Join Sanofi’s Board of Directors". Paris....
- [2] MeiraGTx Holdings plc. (8/12/24). "Press Release: MeiraGTx Announces Pricing of Offering of Ordinary Shares Led by Sanofi". London & New York, NY....
- [3] Sanofi S.A.. (5/13/24). "Press Release: Sanofi Adds over €1 Billion for Biomanufacturing to €2.5 Billion Already Committed in Major Projects in France to Support Health Sovereignty". Paris....
- [4] Sartorius AG. (5/13/24). "Press Release: Sartorius Collaborates with Sanofi to Commercialize End-to-end Platform for Downstream process intensification". Göttingen....
- [5] Owkin. (3/21/24). "Press Release: Owkin Expands Collaboration with Sanofi Leveraging AI for Drug Positioning in immunology"....
- [6] GenSight Biologics S.A.. (12/22/23). "Press Release: GenSight Biologics Appoints Laurence Rodriguez as Chief Executive Officer". Paris....
- [7] Sanofi S.A.. (12/11/23). "Press Release: Statement on FTC Challenge to Proposed License Agreement with Maze Therapeutics". Paris....
- [8] Eligo Bioscience S.A.. (12/5/23). "Press Release: Eligo Bioscience Raises $30 Million To Write a Novel Chapter for Genetic Medicines". Paris....
- [9] Aqemia SAS. (12/5/23). "Press Release: Aqemia Announces a Major Multi-year Collaboration of $140 Million with Sanofi". Paris....
- [10] MeiraGTx Holdings plc. (10/30/23). "Press Release: MeiraGTx Announces $30 Million Strategic Investment from Sanofi; Company Pursuing Multiple Additional Strategic Opportunities". London & New York, NY....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top